Overview
VYNE market data
Price History
VYNE price chart · 1M
- O
- 24.94
- H
- 25.19
- L
- 24.94
- C
- 25.14
- Vol
- 2,419.00
- Source
- US equities market feed
- Observed
- Jul 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $24.94
- Previous Close
- $25.45
- Day High
- $25.19
- Day Low
- $24.94
- 52 Week High
- $27.26
- 52 Week Low
- $16.94
- 7 Day Return
- +13.14%
- 30 Day Return
- +38.90%
- 90 Day Return
- +44.07%
- 1 Year Return
- +44.07%
- Daily Notional Volume
- $60.8K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$30.96 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.09 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -8,328.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $14.03 – $46.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $93.5M · P/B 0.70 · P/S 158.10.
Company News
8-K/A filing — Yarrow Bioscience, Inc. (VYNE)SEC EDGAR · Aug 13, 2026, 8:14 PM
8-K filing — Yarrow Bioscience, Inc. (VYNE)SEC EDGAR · Jul 28, 2026, 9:11 PM
Yarrow Bioscience And VYNE Therapeutics Compete Merger With Previously Announced Private Financings Totaling ~$200M; To Operate As Yarrow Bioscience And Trade On Nasdaq Capital Market From July 28 Under Ticker Symbol 'YARW'Benzinga · Jul 27, 2026, 11:29 AM
VYNE Therapeutics shares are trading lower after the company announced a 1-for-50 reverse stock split.Benzinga · Jul 24, 2026, 11:53 AM
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 24, 2026, 8:35 AM
VYNE Therapeutics Announces 1-For-50 Reverse Stock Split, Effective July 24Benzinga · Jul 23, 2026, 8:34 PM
8-K filing — VYNE Therapeutics Inc. (VYNE)SEC EDGAR · Jul 21, 2026, 12:14 PM
Vyne Therapeutics Announces 1-For-50 Reverse Stock Split, Special Dividend Of $0.40242/Share Payable To Shareholders Of Record As Of July 22Benzinga · Jul 21, 2026, 12:12 PM
Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving PremarketBenzinga · Jul 21, 2026, 9:11 AM
VYNE Therapeutics Announces Special Cash Dividend Of $0.38/ShareBenzinga · Jul 10, 2026, 12:05 PM